An Indian pharmaceutical giant has been forced to shut operations at several global facilities after suffering an unspecified cyber-attack. Dr Reddy’s, which produces COVID-19 treatments remdesivir and favipiravir and has just signed a deal to manufacture Russia’s Sputnik-V vaccine, saw shares plummet by over 4% following the announcement.

Read full article on Infosecurity